Canaccord Genuity Starts Ascendis Pharma (ASND) at Buy

August 7, 2018 5:21 AM EDT Send to a Friend
Canaccord Genuity initiates coverage on Ascendis Pharma (NASDAQ: ASND) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login